(Q51367050)

4 April 2018

title

U-100, pH-Neutral formulation of VIAject(®) : faster onset of action than insulin lispro in patients with type 1 diabetes. (English)

1 reference

4 April 2018

0 references

1 reference

L Heinemann

1

1 reference

4 April 2018

L Nosek

2

1 reference

4 April 2018

F Flacke

3

1 reference

4 April 2018

K Albus

4

1 reference

4 April 2018

A Krasner

5

1 reference

4 April 2018

P Pichotta

6

1 reference

4 April 2018

T Heise

7

1 reference

4 April 2018

S Steiner

8

1 reference

4 April 2018

publication date

13 November 2011

1 reference

4 April 2018

Diabetes, Obesity and Metabolism

published in

1 reference

4 April 2018

volume

14

1 reference

4 April 2018

issue

3

1 reference

4 April 2018

page(s)

222-227

1 reference

4 April 2018

Premeal injection of rapid-acting insulin reduces postprandial glycemic excursions in type 1 diabetes.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01516.X

Timing of meal insulin boluses to achieve optimal postprandial glycemic control in patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01516.X

A feasibility study of bihormonal closed-loop blood glucose control using dual subcutaneous infusion of insulin and glucagon in ambulatory diabetic swine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01516.X

A novel insulin formulation with a more rapid onset of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01516.X

Reduction of postprandial glycemic excursions in patients with type 1 diabetes: a novel human insulin formulation versus a rapid-acting insulin analog and regular human insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01516.X

Insulin glulisine: a faster onset of action compared with insulin lispro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01516.X

Time-action profile of inhaled insulin in comparison with subcutaneously injected insulin lispro and regular human insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01516.X

Two-year pulmonary safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01516.X

A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01516.X

10.1111/J.1463-1326.2011.01516.X

21 January 2018

Identifiers

DOI

1 reference

4 April 2018

release_2ict5qodwrht7kq6wx3mcwn6bi

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2ict5qodwrht7kq6wx3mcwn6bi

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

21981286

1 reference

4 April 2018